Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
PRESS RELEASE GLP-1 Weight Loss Users Are Seeking Smaller Pack Sizes and Foods with Functional Benefits, according to new study from AMC Global and OpinionRoute AMC Global, an international custom market research firm specializing in launch strategies and brand tracking, and OpinionRoute, a leader in insights process management, have released a new study on GLP-1 medication users and food choices
SURPASS-5 (PMID 35133415) tested tirzepatide as add-on to titrated insulin glargine, demonstrating glycemic improvements without disproportionate hypoglycemia
One important detail in altRx's published terms: medication is considered dispensed and the order completed when it is signed out for shipping, not when it arrives
A recent cross-sectional study involving 124 participants indicated that 56% of patients still exhibited elevated residual gastric contents despite halting incretin agonists for a minimum of 7 days, thus challenging the practice of discontinuing long-acting GLP-1 RAs solely for this duration prior to surgery [19]
